These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 1251339

  • 21. Determination of fibrinogen in normal human plasma in the presence and absence of anticoagulants.
    Roberts PS, Regelson W, Kingsbury B.
    J Lab Clin Med; 1973 Nov; 82(5):822-8. PubMed ID: 4746821
    [No Abstract] [Full Text] [Related]

  • 22. [Analysis of the stability of the intermediate fibrin polymers formed in a fibrinogen-thrombin system].
    Ugarova TP, Lugovskoĭ EV, Gorkun OV, Derzskaia SG.
    Ukr Biokhim Zh (1978); 1983 Nov; 55(3):254-9. PubMed ID: 6868148
    [Abstract] [Full Text] [Related]

  • 23. A rapid, quantitative determination of clottable fibrinogen unaffected by heparin.
    Hershgold EJ, Martin B.
    Am J Clin Pathol; 1975 Feb; 63(2):231-6. PubMed ID: 1115033
    [Abstract] [Full Text] [Related]

  • 24. Molecular aspects of the clottable proteins of human plasma during fibrinogenolysis.
    Ly B, Kierulf P, Arnesen H.
    Thromb Res; 1974 Sep; 5(3):301-14. PubMed ID: 4216116
    [No Abstract] [Full Text] [Related]

  • 25. Heparin precipitable fraction in hemorrhagic skin changes. II. The value of HPF determinations in purpura hyperergica (arteriolitis "allergica" Ruiter).
    Jablonska S, Rzesa G, Kalinowska J.
    Dermatologica; 1966 Sep; 133(6):487-94. PubMed ID: 6007530
    [No Abstract] [Full Text] [Related]

  • 26. [alphaC domains of fibrinogen molecules as the structures accelerating fibrin assembly].
    Medved' LV, Gorkun OV, Maniakov VF, Belitser VA.
    Mol Biol (Mosk); 1986 Sep; 20(2):461-70. PubMed ID: 3702870
    [Abstract] [Full Text] [Related]

  • 27. Characterization of serum fibrinogen and fibrin fragments produced during disseminated intravascular coagulation.
    Lane DA, Preston FE, VanRoss ME, Kakkar VV.
    Br J Haematol; 1978 Dec; 40(4):609-15. PubMed ID: 365218
    [Abstract] [Full Text] [Related]

  • 28. A study of the conditions and accuracy of the thrombin time assay of plasma fibrinogen.
    Jespersen J, Sidelmann J.
    Acta Haematol; 1982 Dec; 67(1):2-7. PubMed ID: 6800197
    [Abstract] [Full Text] [Related]

  • 29. New method for determining thrombin-clottable fibrinogen.
    Frigola A, Angeloni S, Cerqueti AR.
    Clin Chem; 1977 Nov; 23(11):2103-6. PubMed ID: 912875
    [Abstract] [Full Text] [Related]

  • 30. Carboxyl-terminal structures of mammalian fibrinogen and fibrin.
    Iwanaga S, Okude M.
    Ann N Y Acad Sci; 1972 Dec 08; 202():308-17. PubMed ID: 4508930
    [No Abstract] [Full Text] [Related]

  • 31. A 96-well microfiltration assay for measurement of total clottable fibrinogen.
    Dempfle CE, Keller A, Argirion S, Heene DL.
    Thromb Haemost; 1999 Feb 08; 81(2):264-7. PubMed ID: 10064004
    [Abstract] [Full Text] [Related]

  • 32. Characterization of fibrinogen and fibrin degradation products by isoelectric focusing in polyacrylamide gel.
    Arnesen H.
    Thromb Res; 1974 Jun 08; 4(6):861-8. PubMed ID: 4844064
    [No Abstract] [Full Text] [Related]

  • 33. Elevated heparin-precipitable fraction of plasma in granuloma annulare.
    Dahl MV, Cherney KJ, Lindroos WE.
    Arch Dermatol; 1979 Sep 08; 115(9):1059-60. PubMed ID: 485181
    [Abstract] [Full Text] [Related]

  • 34. Comparison of three methods for plasma fibrinogen.
    Saleem A, Fretz K, Krieg AF.
    Ann Clin Lab Sci; 1976 Sep 08; 6(1):65-71. PubMed ID: 1247285
    [Abstract] [Full Text] [Related]

  • 35. Prevalence and clinical implications of heparin-associated false positive tests for serum fibrin(ogen) degradation products.
    Connaghan DG, Francis CW, Ryan DH, Marder VJ.
    Am J Clin Pathol; 1986 Sep 08; 86(3):304-10. PubMed ID: 3751995
    [Abstract] [Full Text] [Related]

  • 36. [On the behavior of a heparin-precipitable plasma fraction (H.P.F.) in dermatology].
    Bonelli U.
    Arch Ital Dermatol Venereol Sessuol; 1969 Sep 08; 36(1):46-58. PubMed ID: 5383626
    [No Abstract] [Full Text] [Related]

  • 37. Enhancement of blood coagulation by soluble fibrin complexes.
    Hansen MS, Bang NU, Barton RD, Mattler LE.
    J Exp Med; 1975 May 01; 141(5):944-61. PubMed ID: 805207
    [Abstract] [Full Text] [Related]

  • 38. Activated protein C inhibitor.
    Suzuki K.
    Semin Thromb Hemost; 1984 Apr 01; 10(2):154-61. PubMed ID: 6330903
    [No Abstract] [Full Text] [Related]

  • 39. A batch method for estimating thrombin clottable fibrinogen.
    Farrell GW, Wolf P.
    J Clin Pathol; 1973 Oct 01; 26(10):764-9. PubMed ID: 4750457
    [Abstract] [Full Text] [Related]

  • 40. A comparative study of crosslinked and noncrosslinked fibrin from the major classes of vertebrates.
    Schwartz ML, Pizzo SV, Sullivan JB, Hill RL, McKee PA.
    Thromb Diath Haemorrh; 1973 May 10; 29(2):313-38. PubMed ID: 4762256
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.